C-type Natriuretic Peptide Analog class drugs
1 result
Voxzogo 0.4mg (vosoritide)
(vosoritide)BioMarin Pharmaceutical Inc.
Usage: VOXZOGO is indicated for increasing linear growth in pediatric patients with achondroplasia who have open epiphyses. This approval, granted under accelerated conditions, relies on improved annualized growth velocity, with continued use subject to further validation of clinical benefit in future trials.